CRISPR Therapeutics Management
Management criteria checks 3/4
CRISPR Therapeutics' CEO is Sam Kulkarni, appointed in Dec 2017, has a tenure of 6.42 years. total yearly compensation is $12.32M, comprised of 5.9% salary and 94.1% bonuses, including company stock and options. directly owns 0.48% of the company’s shares, worth CHF19.92M. The average tenure of the management team and the board of directors is 5.5 years and 4.9 years respectively.
Key information
Sam Kulkarni
Chief executive officer
US$12.3m
Total compensation
CEO salary percentage | 5.9% |
CEO tenure | 6.4yrs |
CEO ownership | 0.5% |
Management average tenure | 5.5yrs |
Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$12m | US$725k | -US$154m |
Sep 30 2023 | n/a | n/a | -US$354m |
Jun 30 2023 | n/a | n/a | -US$416m |
Mar 31 2023 | n/a | n/a | -US$524m |
Dec 31 2022 | US$21m | US$700k | -US$650m |
Sep 30 2022 | n/a | n/a | -US$681m |
Jun 30 2022 | n/a | n/a | -US$633m |
Mar 31 2022 | n/a | n/a | US$312m |
Dec 31 2021 | US$17m | US$670k | US$378m |
Sep 30 2021 | n/a | n/a | US$412m |
Jun 30 2021 | n/a | n/a | US$447m |
Mar 31 2021 | n/a | n/a | -US$392m |
Dec 31 2020 | US$9m | US$625k | -US$349m |
Sep 30 2020 | n/a | n/a | -US$211m |
Jun 30 2020 | n/a | n/a | US$20m |
Mar 31 2020 | n/a | n/a | US$46m |
Dec 31 2019 | US$16m | US$550k | US$67m |
Sep 30 2019 | n/a | n/a | -US$11m |
Jun 30 2019 | n/a | n/a | -US$200m |
Mar 31 2019 | n/a | n/a | -US$185m |
Dec 31 2018 | US$10m | US$518k | -US$165m |
Sep 30 2018 | n/a | n/a | -US$117m |
Jun 30 2018 | n/a | n/a | -US$91m |
Mar 31 2018 | n/a | n/a | -US$75m |
Dec 31 2017 | US$7m | US$405k | -US$68m |
Compensation vs Market: Sam's total compensation ($USD12.32M) is above average for companies of similar size in the Swiss market ($USD1.69M).
Compensation vs Earnings: Sam's compensation has been consistent with company performance over the past year.
CEO
Sam Kulkarni (45 yo)
6.4yrs
Tenure
US$12,322,196
Compensation
Dr. Samarth Kulkarni, Ph D., also known as Sam, has been an Independent Director of Repare Therapeutics Inc. since November 2019. Dr. Kulkarni serves as an Independent Non-Executive Director of Centessa Ph...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 6.4yrs | US$12.32m | 0.48% $ 19.9m | |
Chief Financial Officer | 1.2yrs | US$5.91m | 0.012% $ 488.1k | |
General Counsel & Secretary | 7yrs | US$3.51m | 0.072% $ 3.0m | |
Founder | no data | no data | no data | |
Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Head of Technical Operations | 4.6yrs | no data | no data | |
Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
Head of Human Resources | no data | no data | no data |
5.5yrs
Average Tenure
48yo
Average Age
Experienced Management: 1CG's management team is seasoned and experienced (5.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 5.9yrs | US$12.32m | 0.48% $ 19.9m | |
Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Scientific Founder & Advisory Board Member | no data | no data | no data | |
Lead Independent Director | 3.9yrs | US$552.56k | 0.0024% $ 97.8k | |
Independent Director | 9.1yrs | US$545.06k | 0.00032% $ 13.3k | |
Independent Director | 4.9yrs | US$532.56k | 0% $ 0 | |
Independent Director | 9.1yrs | US$542.56k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 4.9yrs | US$555.06k | 0% $ 0 | |
Independent Director | 2.9yrs | US$536.24k | 0% $ 0 |
4.9yrs
Average Tenure
57yo
Average Age
Experienced Board: 1CG's board of directors are considered experienced (4.9 years average tenure).